Results 141 to 150 of about 53,863 (261)

Design and Characterization of a Bioinspired PAMAM@Poly(Caffeic Acid) Magnetite Nanocarrier for Curcumin Delivery. [PDF]

open access: yesACS Omega
Foti A   +5 more
europepmc   +1 more source

CO2‐Responsive Dual‐Charge‐Switchable Membranes for Protein Foulant Cleaning

open access: yesMacromolecular Rapid Communications, EarlyView.
CO2‐responsive poly(ether sulfone) ultrafiltration membranes with dual‐charge‐switchable surfaces are prepared by incorporating an amphoteric diblock copolymer additive using the nonsolvent‐induced phase separation method. Alternating CO2 and N2 bubbling changes the solution pH around the copolymer isoelectric point and hence reversibly switches the ...
Niloofar Zamanian, Yue Zhao
wiley   +1 more source

Synthesis and molecular structure of a novel barium arylspiroboronate ester

open access: yesOpen Chemistry, 2011
Halcovitch Nathan   +4 more
doaj   +1 more source

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri   +20 more
wiley   +1 more source

Mussel-Inspired Catechol-Functionalized Redox-Active Polypeptides for Energy Applications. [PDF]

open access: yesBiomacromolecules
Li SG   +9 more
europepmc   +1 more source

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real‐World, Monocentric, Observational Study and Critical Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig   +6 more
wiley   +1 more source

Peptide‐based antibacterial nanoplatforms: Design principles, stimuli‐regulated behaviors, and applications

open access: yesResponsive Materials, EarlyView.
Peptide‐based antibacterial nanoplatforms, encompassing self‐assembled peptides and peptide‐engineered inorganic, polymeric, and lipid nanocarriers, are systematically reviewed. The article highlights design principles and stimuli‐responsive regulation for improving peptide stability, delivery efficiency, and antibacterial performance.
Peng Tan   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy